Global Glycomics/Glycobiology Market – Industry Trends and Forecast to 2029

Glycomics/Glycobiology Market Analysis and Size

One of the most frequent alterations for cell survival is the attachment of glycans. Two types of glycosylation exist. One is N-linked glycosylation: Asparagine glycan attachment and other is O-linked glycosylation: when the glycan is connected to a serine or threonine. Glycomics is a rapidly developing scientific subject that focuses on explaining how glycans operate in biosystems.

Data Bridge Market Research analyses that the glycomics/glycobiology market which was USD 16.4 billion in 2021, would rocket up to USD 47.44 billion by 2029, and is expected to undergo a CAGR of 14.2% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Glycomics/Glycobiology Market Scope and Segmentation      

Market Definition

The study of saccharides, which are extensively distributed in nature and are also thought as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Each and every living thing contains glycans. Biotechnology, biomedicine, and basic research are all interested in glycobiology's rapidly developing biological topic.

Glycomics/Glycobiology Market Dynamics

Drivers

• Technological advancements

Technological advancements are thought to promote corporate expansion. Other important aspects that operate as determinants include rising analysis spending by various administration groups and the development of novel drugs by biotechnology and pharmaceutical firms. Additionally, throughout the 2022–2029 forecast period, increasing interest in proteomics examination learnings is anticipated to fuel market growth.

• Rising R&D expenditures

The market is expanding primarily due to rising glycomics research efforts, rising R&D expenditures by pharmaceutical and biotechnology firms, and expanding proteomics sales. On the other hand, developing nations like China and India provide profitable chances for business in this sector.

• Rise in the geriatric population

The rising prevalence of disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the global glycomics/glycobiology market.

Opportunities

The market for glycomics and glycobiology is being driven primarily by rising investments in research and development by pharmaceutical and biotechnology businesses and expansion in the proteomics sector. For other businesses in this industry, developing nations provide lucrative opportunities.

Restraints/Challenges

On the other hand, the huge expense of devices will obstruct the market's growth rate.

This glycomics/glycobiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycomics/glycobiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Glycomics/Glycobiology Market

In order to combat the COVID-19 epidemic, governments from all over the world work with pharmaceutical and biotech businesses. This collaboration ranges from helping to develop vaccines to preparing for issues with the pharmaceutical supply chain. Currently, there are 115 vaccine candidates and about 155 chemicals in the R&D pipeline. In addition, there has been a substantial rise in demand for commonly prescribed drugs like hydroxychloroquine, which is used to treat COVID-19. Due to the dearth of these treatments in many industrialised countries, there is a huge market opportunity for manufacturers of COVID-19 management therapies. The demand for COVID-19 vaccines and treatment drugs is expected to result in significant growth for the pharmaceutical and biotechnology industries in the upcoming years.

Global Glycomics/Glycobiology Market Scope

The glycomics/glycobiology market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Enzymes
• Glycosidases and Neuramidases
• Glycosyltransferases and Sialytransferases
• Other Enzymes
• Carbohydrate kinases
• Carbohydrate sulfotransferases
• Protein sulfotransferases
• Sulfatases
• Instruments
• Mass Spectrometry Instruments
• Chromatography Instruments
• Arrays
• Other Instruments
• electrophoresis instruments
•  NMR instruments
• HPLC columns
• Kits
• Glycan Releasing Kits
• Glycan Labeling Kits
• Glycan Purification Kits
• Other Kits
• Glycan detection kits
• Glycan enrichment kits
• Glycan sample preparation kits
• Carbohydrates
• Oligosaccharides
• Monosaccharides
• Other Carbohydrates
• Rare sugars
• Glycoproteins
• Glycolipids
• Glycol peptides

• Reagents and Chemicals

Application

• Drug Discovery and Development
• Disease Diagnostics
• Other Applications
• Virology
• Cell biology
• Microbiology

End-user

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories

 Glycomics/Glycobiology Market Regional Analysis/Insights

The glycomics/glycobiology market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.

The countries covered in the glycomics/glycobiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the glycomics/glycobiology market due to increased funding for glycomics research, rising R&D spending in pharmaceutical companies for the creation of new medicines, and the close proximity of the necessary personnel.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the rising health awareness among the people and rising demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Glycomics/Glycobiology Market Share Analysis

The glycomics/glycobiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycomics/glycobiology market.

Some of the major players operating in the glycomics/glycobiology market are:

• Merck KGaA (Germany)
• Agilent Technologies Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Shimadzu Corporation (Japan)
• Takara Bio Inc. (Japan)
• Waters Corporation (U.S.)
• Asparia Glycomics S.L. (Spain)
• Bio-Techne (U.S.)
• Bruker (U.S.)
• Danaher (U.S.)
• RayBiotech, Life Inc.  (U.S.)
• Z Biotech LLC (U.S.)
• Chemily Glycoscience (U.S.)
• Dextra Laboratories Ltd. (U.K.)
• Lectenz Bio (U.S.)
• Ludger Ltd. (U.K.)

SKU-53005